ABSTRACT: An acute wheezing episode is the most common feature of severe lower respiratory tract infection during infancy. Respiratory syncytial virus (RSV) is the major causative agent.
An acute wheezing episode is the most common severe lower respiratory tract infection in infancy. During epidemics, over 80% of cases may be caused by a respiratory syncytial viral (RSV) infection [1] . Although symptoms may become severe, most infections are selflimited, and improvement usually occurs within several days [2, 3] . Approximately 2% of infants under 2 yrs of age require hospitalization [4] . In severe acute wheezing episodes, necrosis of the respiratory epithelium, excessive production of mucus, and lymphocytic infiltration result in oedema, dense plugs of debris and subsequent bronchiolar obstruction. The role of eosinophil activation in RSV infection needs to be clarified. It has been observed that nasal or pharyngeal secretions recovered from infants suffering from RSV infection have increased eosinophil cationic protein (ECP) levels. A correlation between ECP levels and severity was noted in one study [5] , but ECP levels were found to be similar to those of healthy infants in two other studies [6, 7] . However, no study has yet examined inflammatory markers in the pharyngeal secretions of infants.
A study was carried out during a viral infection episode in 45 infants suffering from acute wheezing episodes requiring hospitalization, and pharyngeal secretions were recovered by physiotherapy. The safety of the procedure was carefully monitored. Inflammatory cells were counted and inflammatory markers were measured in order to differentiate inflammation in infants suffering from acute wheezing episodes with RSV infection (RSV+) or without RSV infection (RSV-).
Materials and methods

Study population
Fourty five infants (1-24 months of age) experiencing acute wheezing episodes severe enough to require hospitalization were included in the study from December to March. Informed consent was obtained from all parents. The diagnosis of acute wheezing episodes was based on symptoms, i.e. tachypnoea, dyspnoea, prolonged expiration and wheezing. Patients with pneumonia on chest radiography were excluded [8] , as were patients with bronchopulmonary dysplasia, congenital heart disease or cystic fibrosis. Antibiotic use was not an exclusion criterion. Children with secondary pulmonary condensation or bacterial superinfection were not excluded. At the time of admission, all infants were treated with inhaled β 2 -agonist bronchodilators.
Virus identification
RSV was identified in nasopharygeal secretions by direct immunofluorescence assay (IFA) using monoclonal antibodies to RSV (clone 18B2; Argène, Varilhes, France) and by viral isolation onto MRC-5 cell cultures in 25 cm 2 tissue culture flasks [9] . IFA was also used for identification of influenza virus A (clone IA52; Marne la Coquette, France) and influenza virus B (clone IB82; Sanofi Diagnostics Pasteur, Marne la Coquette France), parainfluenza virus type 1 (clones 11-H9-13; Argène) type 2 (clone 128-33; Argène) and type 3 (clone 5-12; Argène) and adenovirus (Monofluokit adenovirus; Sanofi Diagnostics Pasteur). Other viruses, such as rhinoviruses, cytomegalovirus (CMV) or herpes simplex virus (HSV), were identified by the production of their characteristic cytopathic effect in MRC-5 cultures. HSV typing was performed by immunofluorescence, using monoclonal antibodies.
Sampling of pharyngeal secretions
Samples of pharyngeal secretions were collected on the first day of hospitalization. Sampling of pharyngeal secretion was carried out using chest physiotherapy. After a 20 min nebulization period with prewarmed (25°C) isotonic saline (DeVilbiss 65 ultrasonic nebulizer), chest physiotherapy was performed. A nasal lavage with 5 mL of sterile isotonic saline solution was first performed (twice), removed by suction and discarded. Acceleration of expiratory flow technique was induced by a skilled paediatric physiotherapist. Pharyngeal secretions were then collected by gentle nasopharyngeal aspiration using a sterile kit (Aspirateur de mucosité, Vygon, Ecouen, France). All samples were collected between 07:00 and 08:00 h after a 4 h fasting period. All samples were immediately treated for analysis.
Safety of pharyngeal secretion sampling
The safety of the pharyngeal secretion production was carefully studied: respiratory frequency, cardiac frequency with electrocardiography (ECG) (Physiogard SM785; Wissembourg, France, USA), and pulse oximetry (Nellcor, N180; Hayward, CA, USA) were monitored throughout the procedure.
Analysis of pharyngeal secretions
The volume of the secretion sample was measured, then incubated with dithiothreitol (DTT, 10 -7 M; Sigma Chemical Co., St Louis, MO, USA). The volume of DTT used ranged from 100 µL to 1 mL according to the volume of the sample (1/1 v/v). The sample was agitated in a vortex mixer for 30 s and the mixture was then drawn up into a plastic pipette and expelled repeatedly (20×) to obtain a fluid sample. Phosphate-buffered saline (PBS) solution (pH 7.4) was added and the sample was mixed using a vortex mixer for another 30 s.
Total cell counts, and viability were determined using a haemocytometer. Viability was assessed using trypan blue exclusion. The cell suspension (70 µL), adjusted to 1×10 6 cells·mL -1 , was centrifuged in a Shandon 2 cytocentrifuge (5 min at 500 rpm). One slide was stained with Diff Quick® (RAL, Paris, France) for differential cell counts on at least 200 cells. A second slide was stained with the monoclonal antibody EG2 in order to distinguish activated eosinophils [10] (Kabi-Pharmacia Diagnostics, Uppsala, Sweden). A third slide was stained with toluidine blue to assess metachromatic cells.
The supernatant was stored at -20°C until analysis. The protein content of the fluid sample was measured with BCA protein assay (Pierce, Rockford, IL, USA). Histamine was measured using enzyme immunoassay [11] (Immunotech, Marseille, France) according to the instructions given on the package insert. ECP was measured using radioimmunoassay [12] (Kabi-Pharmacia Diagnostics) following the manufacturer's instructions. Histamine and ECP levels were expressed as concentration of mediator per unit of volume (µg·mL -1 ) or per milligram of protein (µg·mg -1 ) of the pharyngeal secretion.
Statistical analysis
Results were expressed as median values with interquartile range. Differences between groups were analysed using nonparametric tests (Mann-Whitney U-test). Correlation analysis was performed using Spearman's rank correlation. Statistical analysis was performed using StatView 4.1 software.
Results
Demographic characteristics of the patients
Patients were then divided into two groups on the basis of the presence of RSV. Demographic characteristics of the patients are presented in table 1. There was no difference in median age between RSV+ and RSVpatients, both when the total population was considered and when males and females were considered separately. Cytomegalovirus was also detected in four RSV+ patients. In the RSV-group, four patients were found to be positive for: rhinovirus (n=1), HSV-1 (n=1), influenza virus A (n=1) and influenza virus B (n=1).
Safety of the procedure
Collection of pharyngeal secretions performed following isotonic saline inhalation was well tolerated in all cases. In particular, none of the infants presented tachycardia over 180 beats·min -1 , or bradycardia below 60 beats·min -1 . Transcutaneous oxygen saturation was always over 80%. 
Total and differential cell counts
The volume of pharyngeal secretion recovered was similar in both groups (table 2) . Total and differential cell counts of the pharyngeal secretion were not statistically different between the two groups (table 2), or between males and females. Metachromatic cells were not recovered from pharyngeal secretion samples. Only five patients in the RSV+ group and seven patients in the RSV-group had eosinophils in pharyngeal secretion eosinophils ( fig. 1) , although, EG2 staining was always negative.
Proteins and mediators
The protein content of the fluid was similar in the two groups (median (interquartile range) 2.7 (1.2-4.8) and 3.0 (0.9-7.1) mg·mL -1 of secretion in RSV+ and RSV-group, respectively). ECP and histamine were measurable in all samples. ECP levels were not significantly different between the two groups, and no significant differences were noticed between males and females. Histamine levels were found to be similar when expressed per unit of volume of recovered pharyngeal secretion (µg·mL -1 ) ( fig. 2a ), but were significantly increased in RSV+ patients when expressed per unit of protein (µg·mg protein -1 ; p<0.01, Mann-Whitney U-test) ( fig. 2b ).
There were no significant correlations between the amounts of ECP and eosinophils (number or percentage) present in pharyngeal secretion, or with the age of the patients.
Discussion
This study has shown that pharyngeal secretions can be safely recovered in infants suffering from acute wheezing episodes and can be analysed for the measurement of inflammatory cells and inflammatory mediators. It was found that eosinophil activation was not increased in infants suffering from RSV acute wheezing episodes in comparison to those suffering from acute wheezing episodes due to other viruses. On the other hand, histamine levels after protein adjustment were increased in RSV+ patients. The diagnosis of RSV infection was based on IFA in combination with RSV isolation in cell culture. IFA is a very sensitive method in the detection of RSV in respiratory samples: 87-92.6% were reported [13, 14] . In our laboratory, the sensitivity of the detection is 89% (unpublished data). Moreover, the sensitivity of the diagnostic method has been enhanced with two consecutive cell cultures. The proportion of RSV-children (55%) in the present study is similar to 
a recent multicentric French study, showing an RSV+ prevalence of 58% in a group of infants with acute wheezing episodes [15] . We have analysed all potential relationships between the inflammatory parameters and clinical status, i.e. hospital stay, duration of the disease, type of treatment, values of blood gas, blood differential cell counts, presence of oxygen therapy and type of drug treatment (data not shown). No relationships were observed. Sputum induction has been proposed as a noninvasive tool for assessing airway inflammation in adult asthmatic subjects [16, 17] . However, the authors have used nebulization of hypertonic saline to induce sputum. Hypertonic saline can cause bronchoconstriction [18, 19] , and such a procedure cannot be used in infants. Moreover, all infants studied have a sufficient production of pharyngeal secretion with isotonic saline. On the other hand, humidification of the airways using isotonic saline significantly increases tracheobronchial clearance in patients with bronchial hypersecretion [20] . Nebulization of isotonic saline is a common supportive treatment for viral acute wheezing episodes [1] . In the present study, this procedure was followed by chest physiotherapy in order to collect an "induced" pharyngeal secretion. This procedure was well tolerated and can be routinely carried out by a paediatric chest physiotherapist. In infants, the noninvasive collection of respiratory tract secretions usually involves a simple nasopharyngeal aspiration [5, 6, 21] . However, these studies do not sample the secretions from the bronchial tree. In the present study, we attempted to collect lower airways secretions and to minimize nasopharyngeal contamination, a nasal lavage being carried out just before the secretion collection. In the absence of a specific marker of nasal secretion, the inevitable contamination by upper airways secretions cannot be assessed.
In the present study, total and differential cell counts of nonsquamous cells were similar to those reported in adults [16, 22] . The percentages were similar to those of cells observed in broncholalveolar lavage (BAL) of infants with RSV infection [23] . Few eosinophils were detected in the pharyngeal secretion, with no significant differences between the two groups. Only one subject in each group exhibited a high percentage of this cell type. The differential on the remaining cells was not different between the two groups. The absence of EG2-positive cells is probably due to the DTT treatment of the pharyngeal secretion [24] . The low number of eosinophils in the pharyngeal secretion was consistent with the absence of eosinophils in the bronchial wall observed in an autopsy series in RSV acute wheezing episodes [25] . Moreover, the peripheral blood eosinophil count from patients with acute wheezing episodes was found to be similar to that in the peripheral blood of control subjects [26] .
In nasopharyngeal secretions from patients with RSV infection, eosinophil activation has been suggested, since higher levels of ECP [5] and sulphidopeptide leukotrienes [27] were found compared to those in RSVpatients. Moreover, high ECP levels (>50 ng·mL -1 ) were predictive of short-term development of wheezing [5] . The present results conflict with these studies, since ECP concentrations were similar in the two groups. The results of the present study are consistent with those reported by others [6, 7] . In the latter study, no statistical difference in ECP/albumin ratio was found between 34 RSV+ and 27 RSV-infants with respiratory tract infection. However, we did not observe a difference in the ECP level of pharyngeal secretions between males and females, as described for the group of patients from El Salvador [7] .
The histamine data must be considered carefully because of the method of expressing the results. The pharyngeal secretion obtained after chest physiotherapy is humidified by nebulization of saline solution, which may result in dilution of the sample. It is, therefore, important to normalize the concentration of histamine (µg·mL -1 ) according to the protein concentration of the sample (mg·mL -1 ) [28] . In this study, histamine levels were not elevated in pharyngeal secretions, but the recovery of the secretions was carried out slightly after the acute phase of infection [28] . However, the presence of tryptase, the major neutral proteinase of human mast cells, which is released in parallel with histamine during degranulation [29] , was reported in sputum sampled during exacerbation of lung inflammation [30] , and in BAL fluid of infants with RSV acute bronchiolitis [31] . It is also hypothesized that histamine is released from basophils via an immunoglobulin E (IgE) mediated process induced by paramyxoviruses [32] . The present data are in agreement with these results observed during respiratory tract viral infection. The presence of histamine was detected in both groups, a higher level being found in RSV+ patients. A relationship between histamine and RSV was observed using an animal model [33] . Elevated plasma levels of histamine have also been observed in patients during acute bronchiolitis [34] .
This study demonstrates that samples of pharyngeal secretions from infants hospitalized with bronchial hypersecretion can be obtained safely. Our results suggest mast cell activation during respiratory syncytial virus positive acute wheezing episodes (histamine release), whereas eosinophil activation seems to be less specific and less prominent in the pathology of this disease. Moreover, the discordant results observed between cellular and mediator composition of the pharyngeal secretion (i.e. the absence of eosinophils and mast cells but the presence of ECP and histamine), may be related to increased permeability of the lung parenchymal tissue. Such analysis of the pharyngeal secretion in infants, performed during the acute phase of the disease, could be useful in evaluating the role of histamine and other inflammatory mediators in the development and the evolution of other inflammatory lung diseases, such as asthma.
